Nac-C Plus Capsules, now available in US and European Markets:
Patents: (WO 2004/028536 A1; WO 94/19325; WO 95/12581; WO 2004/064866 A1)
Synergism of histidyl dipeptides and amino acids proven to be beneficial in ophthalmic treatments.
With the knowledge that there is a natural range of the histidyl dipeptides within mammalian tissues we have investigated possible synergism between them in respect of antioxidant activity in ophthalmic treatments.
Considering the efficacy of N-acetylcarnosine eye drops in the therapeutic treatment of ripe cataracts, we now theorize that, declining visual acuity, along with the onset of ‘halo’ effects and vitreous lesions, including floaters and even elevated Intra-Ocular Pressure, (Glaucoma support information) may likely be due to diminished Glutathione levels within the eye.
In a separate pilot study, ripe, age-related, cataract is significantly reversed over a period of 5 months, with the application of Can-C™ N-acetylcarnosine eye drops (2 drops two times daily) when combined with Nac-C Plus™, 1 capsule (two times daily).